Personalized Breast Cancer Treatment
31 – 40 of 134
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
(
- Contribution to journal › Article
- 2021
-
Mark
Tumor co-expression of progranulin and sortilin as a prognostic biomarker in breast cancer
(
- Contribution to journal › Article
-
Mark
Pam50 intrinsic subtype profiles in primary and metastatic breast cancer show a significant shift toward more aggressive subtypes with prognostic implications
(
- Contribution to journal › Article
-
Mark
Prognostic and predictive impact of stroma cells defined by PDGFRb expression in early breast cancer : results from the randomized SweBCG91RT trial
(
- Contribution to journal › Article
-
Mark
St Gallen 2019 guidelines understage the axilla in lobular breast cancer : a population-based study
(
- Contribution to journal › Article
-
Mark
Validation of the Skåne University Hospital nomogram for the preoperative prediction of a disease-free axilla in patients with breast cancer
(
- Contribution to journal › Article
-
Mark
Cosmetic Outcomes and Symmetry Comparison in Patients Undergoing Bilateral Therapeutic Mammoplasty for Breast Cancer
(
- Contribution to journal › Article
-
Mark
Quality assessment of locoregional breast cancer radiotherapy in the international SENOMAC-trial.
(
- Contribution to journal › Published meeting abstract
-
Mark
High CYP27A1 expression is a biomarker of favorable prognosis in premenopausal patients with estrogen receptor positive primary breast cancer
(
- Contribution to journal › Article
-
Mark
Validated prediction model for positive resection margins in breast-conserving surgery based exclusively on preoperative data
(
- Contribution to journal › Article